CytomX Therapeutics, Inc. (CTMX)

Health Care·equity

$2.57

+4.05% today

Extended hours $2.58

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

25/ 100

Score level

Below average

6 of 6 checks had data

How it compares with the broader market is one of its lowest-scoring factors; business numbers score is below the middle; and price trend score is near the bottom of its range.

CTMX scores higher than 21% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, CytomX Therapeutics, Inc. (CTMX) scores 25 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.78× 30-day average
52-week range: 2.43 – 8.21
Market cap: $601.40M
Earnings date: 4 Nov 2026

Volume: 3,040,169
Avg. volume (30d): 3,917,130

Open: 2.46
Previous close: 2.47
Day's range (regular session): 2.44 – 2.58

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: —
P/E (TTM): —
EPS (TTM): —

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for CTMX

1 SEC Form 4 insider transaction in the last 90 daysPremium

Counts of rows Market Census holds for CTMX. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about CTMX right now

CytomX Therapeutics, Inc. (CTMX) currently scores 25/100 on the Market Census six-factor composite, at the Below average score level. CTMX is +4.05% on the day and +0.20% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of CTMX's data reads poorly than well. The level is a "look before you act" flag. It is not advice. CTMX's strongest factor is insider trades at 50/100 — a fairly good read on insider buying and selling. Insider filings do not lean toward buying or selling right now — a plain read of public filings, not a signal to follow. The weakest factor is strength vs the market at 6/100 — well below average next to the wider market.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See CTMX in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score